Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
Soon Sun KimHyo-Jung ChoJi Sun NamHyun-Ji KimDae Ryong KangJe Hwan WonJinoo KimJai Keun KimJei Hee LeeBo Hyun KimMi Young LeeSung Won ChoJae-Youn CheongPublished in: Journal of Korean medical science (2018)
Combination of plasma miRNA-21, -26a, and -29a-3p expression could predict early TACE refractoriness in patients with TACE-treated HCC.